In addition to Michael A Klayko, 2 other MDRX executives reported Sell trades in the last month.
The company has a one-year high of $18.21 and a one-year low of $5.77. Currently, Allscripts has an average volume of 807.91K. MDRX’s market cap is $2.53 billion and the company has a P/E ratio of 3.90.
Based on 7 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $17.29, reflecting a 3.8% upside.
The insider sentiment on Allscripts has been negative according to 58 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Michael A Klayko’s trades have generated a -1.7% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, connectivity, information solutions, and related professional services. It operates through the following segments: Clinical and Financial Solutions; Population Health; and Netsmart. The Clinical and Financial Solutions segment involves in the sale of clinical software applications and financial and information solutions. The Population Health segment offers health management and coordinated care solutions. The Netsmart segment operates in the home care and behavioral healthcare information technology field throughout the United States. The company was founded in 1986 and is headquartered in Chicago, IL.